Côd QR

Application of a Novel Proteomic Microarray Reveals High Exposure to Diarrhoeagenic <i>Escherichia coli</i> among Children in Zambia Participating in a Phase I Clinical Trial

Diarrhoeagenic <i>E. coli</i> (DEC) significantly contributes to the burden of diarrhoea among children. Currently, there is no approved vaccine against DEC, but several vaccines against the enterotoxigenic <i>E. coli</i> (ETEC) pathotype are in advanced clinical trial stages, including the ETVAX<su...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Kapambwe Mwape, Cynthia Mubanga, Obvious Nchimunya Chilyabanyama, Kennedy Chibesa, Caroline Cleopatra Chisenga, Suwilanji Silwamba, Arlo Randall, Xiaowu Liang, Tobias George Barnard, Michelo Simuyandi, Roma Chilengi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI AG 2024-02-01
Cyfres:Microorganisms
Pynciau:
microarray
vaccines
diarrhoeagenic <i>E. coli</i>
diarrhoea
cross-reactivity
ETVAX vaccine
Mynediad Ar-lein:https://www.mdpi.com/2076-2607/12/3/420
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg